title: APOA1/A5 variants and haplotypes as a risk factor for obesity and better lipid profiles in a Brazilian Elderly Cohort.
abstract: Genetic variations in the APOA1/C3/A4/A5 gene cluster have been studied and proposed to be the leading key for susceptibility to cardiovascular diseases and age-associated disorders. We aimed to investigate the associations of rs12721026 (APOA1) and rs1729408 (APOA5) polymorphisms and their haplotypes with some age-related diseases, as well as with lipids and proteins serum levels in a cohort from a Brazilian Elderly Longitudinal Study (EPIDOSO). Genotyping was performed by polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP). Statistical analyses were carried out using logistic regression analysis, Student's t-test, and linkage disequilibrium (LD) analysis. Polymorphic allele frequencies were 0.095 and 0.449 for rs12721026 and rs1729408, respectively. The C-allele of rs1729408 was associated with higher high-density lipoprotein (HDL) (P = 0.022) and glycated hemoglobin levels (P = 0.020). We also showed that rs12721026 and rs1729408 were in LD. The GC haplotype, which is composed of the G-allele of rs12721026 and the C-allele of rs1729408, was significantly associated with obesity (P = 0.028), with higher glycated hemoglobin (P = 0.006), and fasting glucose (P = 0.0003) compared to the TT haplotype, which includes the wild-type alleles of both polymorphisms. Moreover, we found an association between the TC haplotype and higher HDL levels (P = 0.0039). This is the first time that haplotypes involving these polymorphisms were evaluated. Our results showed that these polymorphisms were involved in the development of obesity and in alterations of lipids and proteins serum levels in a Brazilian population. The present findings might also clarify the role of these polymorphisms and their haplotypes in lipids and proteins metabolism.
authors.affiliation: Department of Morphology and Genetics, Universidade Federal de São Paulo, São Paulo, Brazil.
authors.forename: Elizabeth Suchi
authors.initials: ES
authors.lastname: Chen
authors.forename: Tatiane Katsue
authors.initials: TK
authors.lastname: Furuya
authors.forename: Diego Robles
authors.initials: DR
authors.lastname: Mazzotti
authors.forename: Vanessa Kiyomi
authors.initials: VK
authors.lastname: Ota
authors.forename: Maysa Seabra
authors.initials: MS
authors.lastname: Cendoroglo
authors.forename: Luiz Roberto
authors.initials: LR
authors.lastname: Ramos
authors.forename: Lara Quirino
authors.initials: LQ
authors.lastname: Araujo
authors.forename: Rommel Rodriguez
authors.initials: RR
authors.lastname: Burbano
authors.forename: Marília
authors.initials: M
authors.lastname: de Arruda Cardoso Smith
mesh_terms: D016632:Apolipoprotein A-I / Q000235:genetics*; D000072040:Apolipoprotein A-V; D001054:Apolipoproteins A / Q000235:genetics*; D001938:Brazil; D015331:Cohort Studies; D005787:Gene Frequency; D014644:Genetic Variation; D005838:Genotype; D006239:Haplotypes; D006801:Humans; D015810:Linkage Disequilibrium; D008055:Lipids / Q000097:blood / Q000235:genetics; D009765:Obesity / Q000453:epidemiology / Q000235:genetics*; D012307:Risk Factors
chemical_list: C437704:APOA5 protein, human; D016632:Apolipoprotein A-I; D000072040:Apolipoprotein A-V; D001054:Apolipoproteins A; D008055:Lipids